Literature DB >> 16800773

Suppression of the tumorigenic phenotype in human oral squamous cell carcinoma cells by an ethanol extract derived from freeze-dried black raspberries.

Kapila A Rodrigo1, Yeshwant Rawal, Robert J Renner, Steven J Schwartz, Qingguo Tian, Peter E Larsen, Susan R Mallery.   

Abstract

Despite focused efforts to improve therapy, 5-yr survival rates for persons with advanced-stage oral squamous cell carcinoma (SCC) remain discouragingly low. Clearly, early detection combined with strategies for local intervention, such as chemoprevention prior to SCC development, could dramatically improve clinical outcomes. Previously conducted oral cavity human chemoprevention trials, however, have provided mixed results. Although some therapies showed efficacy, they were often accompanied by either significant toxicities or circulating antiadenoviral antibodies. It is clearly apparent that identification of nontoxic, effective treatments is essential to prevent malignant transformation of oral epithelial dysplasias. This study employed cell lines isolated from human oral SCC tumors to investigate the effects of a freeze-dried black raspberry ethanol extract (RO-ET) on cellular growth characteristics often associated with a transformed phenotype such as sustained proliferation, induction of angiogenesis, and production of high levels of reactive species. Our results demonstrate that RO-ET suppresses cell proliferation without perturbing viability, inhibits translation of the complete angiogenic cytokine vascular endothelial growth factor, suppresses nitric oxide synthase activity, and induces both apoptosis and terminal differentiation. These data imply that RO-ET is a promising candidate for use as a chemopreventive agent in persons with oral epithelial dysplasia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800773      PMCID: PMC2392889          DOI: 10.1207/s15327914nc5401_7

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  42 in total

1.  Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression.

Authors:  D M Shin; L Mao; V M Papadimitrakopoulou; G Clayman; A El-Naggar; H J Shin; J J Lee; J S Lee; A Gillenwater; J Myers; S M Lippman; W N Hittelman; W K Hong
Journal:  J Natl Cancer Inst       Date:  2000-01-05       Impact factor: 13.506

2.  Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days.

Authors:  Gary D Stoner; Christine Sardo; Glen Apseloff; Dan Mullet; Wayne Wargo; Vickie Pound; Alpana Singh; James Sanders; Robeena Aziz; Bruce Casto; XiaoLi Sun
Journal:  J Clin Pharmacol       Date:  2005-10       Impact factor: 3.126

3.  Human epidermal keratinocytes undergo (-)-epigallocatechin-3-gallate-dependent differentiation but not apoptosis.

Authors:  Sivaprakasam Balasubramanian; Michael T Sturniolo; George R Dubyak; Richard L Eckert
Journal:  Carcinogenesis       Date:  2005-02-17       Impact factor: 4.944

4.  In vitro anti-proliferative activities of ellagic acid.

Authors:  Jack N Losso; Rishipal R Bansode; Alfred Trappey; Hiba A Bawadi; Robert Truax
Journal:  J Nutr Biochem       Date:  2004-11       Impact factor: 6.048

5.  Cellular antioxidant and pro-oxidant actions of nitric oxide.

Authors:  M S Joshi; J L Ponthier; J R Lancaster
Journal:  Free Radic Biol Med       Date:  1999-12       Impact factor: 7.376

6.  VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix.

Authors:  Giannoula Soufla; Stavros Sifakis; Stavroula Baritaki; Alexandros Zafiropoulos; Eugenios Koumantakis; Demetrios A Spandidos
Journal:  Cancer Lett       Date:  2005-04-18       Impact factor: 8.679

7.  VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms.

Authors:  Daniel J Schoeffner; Shannon L Matheny; Takemi Akahane; Valentina Factor; Adam Berry; Glenn Merlino; Unnur P Thorgeirsson
Journal:  Lab Invest       Date:  2005-05       Impact factor: 5.662

8.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

9.  Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.

Authors:  B D Smith; G L Smith; D Carter; C T Sasaki; B G Haffty
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

Review 10.  Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.

Authors:  M W Lingen
Journal:  Crit Rev Oral Biol Med       Date:  1999
View more
  33 in total

1.  A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells.

Authors:  Zhaoxia Zhang; Thomas J Knobloch; Leigh G Seamon; Gary D Stoner; David E Cohn; Electra D Paskett; Jeffrey M Fowler; Christopher M Weghorst
Journal:  Gynecol Oncol       Date:  2011-08-09       Impact factor: 5.482

2.  Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis.

Authors:  David C Montrose; Nicole A Horelik; James P Madigan; Gary D Stoner; Li-Shu Wang; Richard S Bruno; Hea Jin Park; Charles Giardina; Daniel W Rosenberg
Journal:  Carcinogenesis       Date:  2010-11-23       Impact factor: 4.944

3.  Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF.

Authors:  Meng Tong; Brandon Lloyd; Ping Pei; Susan R Mallery
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

4.  Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro.

Authors:  Jillian N Eskra; Alaina Dodge; Michael J Schlicht; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2019-08-12       Impact factor: 2.900

5.  Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention.

Authors:  Susan R Mallery; Gary D Stoner; Peter E Larsen; Henry W Fields; Kapila A Rodrigo; Steven J Schwartz; Qingguo Tian; Jin Dai; Russell J Mumper
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

6.  Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.

Authors:  Kashappa Goud H Desai; Karl F Olsen; Susan R Mallery; Gary D Stoner; Steven P Schwendeman
Journal:  Pharm Res       Date:  2010-02-11       Impact factor: 4.200

Review 7.  Cancer prevention with freeze-dried berries and berry components.

Authors:  Gary D Stoner; Li-Shu Wang; Nancy Zikri; Tong Chen; Stephen S Hecht; Chuanshu Huang; Christine Sardo; John F Lechner
Journal:  Semin Cancer Biol       Date:  2007-05-10       Impact factor: 15.707

8.  Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies.

Authors:  Andrew S Holpuch; Garrett J Hummel; Meng Tong; Garrett A Seghi; Ping Pei; Ping Ma; Russell J Mumper; Susan R Mallery
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

9.  Inherent phenotypic plasticity facilitates progression of head and neck cancer: endotheliod characteristics enable angiogenesis and invasion.

Authors:  Meng Tong; Byungdo B Han; Andrew S Holpuch; Ping Pei; Lingli He; Susan R Mallery
Journal:  Exp Cell Res       Date:  2013-01-29       Impact factor: 3.905

Review 10.  Anthocyanins and their role in cancer prevention.

Authors:  Li-Shu Wang; Gary D Stoner
Journal:  Cancer Lett       Date:  2008-06-20       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.